Because p53 has been suggested to play a role in the anticancer properties of resveratrol, we tested the cytotoxic effects of this compound in the MCF-7 breast cancer, A549 lung cancer and H460 lung cancer cell lines (which express wild-type p53) and in the p53-deficient non-small lung cancer cell line H1299. Here, TP53 is linked to breast carcinoma.